Gene: ANK3

288
ANKYRIN-G|MRT37
ankyrin 3
protein-coding
10q21.2
Ensembl:ENSG00000151150 MIM:600465 Vega:OTTHUMG00000018288 UniprotKB:Q12955
NG_029917.1
PubMed|SNP Mapped
3   ANCO-SNPs
CD|ND|AD
3   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.111e-1 (AD)  7.738e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs1904397chr10:60734102 (GRCh38.p7)C>Acocaine dependenceSNV(Single Nucleotide Variation)
rs10821716chr10:60310995 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10821687chr10:60142442 (GRCh38.p7)C>Tnicotine dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PTPRD0.937
RAPGEF50.937
MFSD60.931
PEX5L0.928
PRUNE20.926
STK390.922
HECW20.92
AKAP60.918
SLC24A20.913
AGTPBP10.913

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
RNF135-0.509
PDZK1IP1-0.503
RHOD-0.499
RAB13-0.482
GJB2-0.482
EVC2-0.475
EMP3-0.471
INHBB-0.47
SOD3-0.466
IMPA2-0.46

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C49562614-deoxy-11,12-didehydroandrographolide"14-deoxy-11,12-didehydroandrographolide results in decreased expression of ANK3 mRNA"22101062
C49562614-deoxy-11,12-didehydroandrographolide"14-deoxy-11,12-didehydroandrographolide results in increased expression of ANK3 mRNA"22101062
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of ANK3 mRNA19933214
C0297902,2',3',4,4',5-hexachlorobiphenyl"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ANK3 mRNA"23829299
C0094072,5,2',5'-tetrachlorobiphenyl"2,5,2',5'-tetrachlorobiphenyl results in increased expression of ANK3 mRNA"23829299
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in decreased expression of ANK3 mRNA"20406850
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of ANK3 mRNA"21346803
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of ANK3 mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of ANK3 mRNA17562736
C016601afimoxifeneafimoxifene inhibits the reaction [Estrogens results in decreased expression of ANK3 mRNA]21233418
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of ANK3 mRNA22100608
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of ANK3 gene27153756
D000643Ammonium ChlorideAmmonium Chloride affects the expression of ANK3 mRNA16483693
C004984apocarotenalapocarotenal results in increased expression of ANK3 mRNA17034753
C006632arsenic trioxidearsenic trioxide results in decreased expression of ANK3 mRNA15761015
C006632arsenic trioxidearsenic trioxide results in increased expression of ANK3 mRNA15761015
D001280AtrazineAtrazine results in decreased expression of ANK3 mRNA25929836
C547126AZM551248AZM551248 results in decreased expression of ANK3 mRNA22323515
C030935benz(a)anthracene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA27858113
C006703benzo(b)fluoranthene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ANK3 mRNA20106945
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ANK3 mRNA20713471|2156981
D019207beta Carotenebeta Carotene results in increased expression of ANK3 mRNA17034753
D004958EstradiolEstradiol affects the expression of ANK3 mRNA23557687
D004958EstradiolEGF protein promotes the reaction [Estradiol results in decreased expression of ANK3 mRNA]24758408
D004958EstradiolEstradiol results in decreased expression of ANK3 mRNA24758408
C095105bexarotenebexarotene results in decreased expression of ANK3 mRNA16648578
C006780bisphenol Abisphenol A results in increased expression of ANK3 mRNA29275510
C006780bisphenol Abisphenol A results in decreased expression of ANK3 mRNA25181051
C013418bromfenacoumbromfenacoum results in decreased expression of ANK3 protein28903499
C018475butyraldehydebutyraldehyde results in decreased expression of ANK3 mRNA26079696
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of ANK3 mRNA17484886
C031180chrysene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA27858113
D002994ClofibrateClofibrate results in decreased expression of ANK3 mRNA23811191
C018021cobaltous chloridecobaltous chloride results in decreased expression of ANK3 mRNA24386269
D003471CuprizoneCuprizone results in decreased expression of ANK3 mRNA27523638
D016572CyclosporineCyclosporine results in decreased expression of ANK3 mRNA20106945
D016572CyclosporineCyclosporine results in decreased expression of ANK3 mRNA19770486
D003907DexamethasoneDexamethasone results in increased expression of ANK3 mRNA22733784
D002945Cisplatin[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of ANK3 mRNA23625948
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ANK3 mRNA"22485181
C118739entinostatentinostat results in decreased expression of ANK3 mRNA27188386
D004967Estrogensafimoxifene inhibits the reaction [Estrogens results in decreased expression of ANK3 mRNA]21233418
D004967EstrogensEstrogens results in decreased expression of ANK3 mRNA21233418
C039281furanfuran results in increased methylation of ANK3 gene22079235
C056507gemcitabinegemcitabine results in increased expression of ANK3 mRNA17039268
C089796hexabromocyclododecanehexabromocyclododecane affects the expression of ANK3 mRNA24680724
D017313FenretinideFenretinide results in increased expression of ANK3 mRNA28973697
C561695(+)-JQ1 compound[(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of ANK3 mRNA25119042
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of ANK3 mRNA23430699|2479639
D007657Ketone BodiesKetone Bodies results in increased expression of ANK3 mRNA16807920
D007854LeadLead affects the splicing of ANK3 mRNA28903495
D058185Magnetite Nanoparticles[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANK3 mRNA26378955
C004925methylmercuric chloridemethylmercuric chloride affects the expression of ANK3 protein27012723
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ANK3 mRNA28001369
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ANK3 mRNA"26251327
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ANK3 promoter"26251327
C008493methylselenic acidmethylselenic acid results in decreased expression of ANK3 mRNA18548127
C523184mocetinostatmocetinostat results in increased expression of ANK3 mRNA27255383
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of ANK3 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of ANK3 mRNA"25620056
D009532NickelNickel results in decreased expression of ANK3 mRNA24768652
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"PON1 gene polymorphism affects the susceptibility to [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the expression of ANK3 mRNA]"21673326
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of ANK3 mRNA"21673326
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"PON1 protein affects the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of ANK3 mRNA]"21673326
C510784ormosil[ormosil binds to Polyethylene Glycols] which results in decreased expression of ANK3 mRNA24888373
D010100OxygenOxygen deficiency results in increased expression of ANK3 mRNA24205000
C016030pantogabpantogab results in decreased expression of ANK3 mRNA17379144
C410127PCB 180PCB 180 results in decreased expression of ANK3 mRNA23829299
C506614PD 0325901[(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of ANK3 mRNA25119042
D010634PhenobarbitalPhenobarbital affects the expression of ANK3 mRNA19159669
D010634PhenobarbitalPhenobarbital affects the expression of ANK3 mRNA23091169
D010634PhenobarbitalPhenobarbital results in increased expression of ANK3 mRNA19162173
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of ANK3 mRNA26272509
D010862PilocarpinePilocarpine results in increased expression of ANK3 mRNA19306853
D010862PilocarpinePilocarpine results in increased expression of ANK3 protein19306853
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANK3 mRNA19710929
C006253pirinixic acidpirinixic acid results in decreased expression of ANK3 mRNA23811191
D011092Polyethylene Glycols[ormosil binds to Polyethylene Glycols] which results in decreased expression of ANK3 mRNA24888373
D011374ProgesteroneProgesterone results in decreased expression of ANK3 mRNA21540246
D011374ProgesteroneProgesterone results in decreased expression of ANK3 mRNA19690047
D011441PropylthiouracilPropylthiouracil results in decreased expression of ANK3 mRNA24780913
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride affects the expression of ANK3 mRNA16079270
D011929RazoxaneRazoxane results in decreased expression of ANK3 mRNA19915844
D012643Selenium[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA19244175
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of ANK3 mRNA25895662
D012822Silicon DioxideSilicon Dioxide results in decreased expression of ANK3 mRNA25351596
C009277sodium arsenatesodium arsenate affects the methylation of ANK3 promoter20667999
C009277sodium arsenatesodium arsenate results in decreased expression of ANK3 mRNA20667999
C009277sodium arsenatesodium arsenate results in increased expression of ANK3 mRNA21795629
C017947sodium arsenitesodium arsenite affects the methylation of ANK3 gene28589171
D012969Sodium FluorideSodium Fluoride results in decreased expression of ANK3 protein28918527
D004113Succimer[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANK3 mRNA26378955
D000952Antigens, Polyomavirus Transforming"Antigens, Polyomavirus Transforming results in decreased expression of ANK3 mRNA"26680231
C004648testosterone enanthatetestosterone enanthate affects the expression of ANK3 mRNA17440010
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of ANK3 mRNA20055451
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ANK3 mRNA21570461|2468072
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ANK3 promoter]19654925
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of ANK3 mRNA19770486|1993321
C483909torcetrapibtorcetrapib results in increased expression of ANK3 mRNA23228038
D014212TretinoinTretinoin results in increased expression of ANK3 mRNA21934132
D014212TretinoinTretinoin results in increased expression of ANK3 protein15894607
D014241TrichloroethyleneTrichloroethylene results in increased methylation of ANK3 gene27618143
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of ANK3 mRNA24935251|2627250
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK3 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of ANK3 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of ANK3 mRNA23179753|2800136
D014635Valproic AcidValproic Acid results in increased expression of ANK3 mRNA23179753|2627250
D001335Vehicle EmissionsVehicle Emissions affects the methylation of ANK3 gene25560391
C025643vinclozolinvinclozolin affects the expression of ANK3 mRNA19015723
C029297vinylidene chloridevinylidene chloride results in decreased expression of ANK3 mRNA26682919
D014810Vitamin E[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA19244175
D014810Vitamin EVitamin E results in decreased expression of ANK3 mRNA19244175
D024483Vitamin K 3Vitamin K 3 affects the expression of ANK3 mRNA20044591

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005200structural constituent of cytoskeleton-IMP17620337  
GO:0005515protein binding-IPI15231748  15611082  19934039  20195357  
GO:0008092cytoskeletal protein binding-ISS21223964  
GO:0030507spectrin binding-ISS-  
GO:0030674protein binding, bridging-ISS-  
GO:0044325ion channel binding-IBA21873635  
GO:0044325ion channel binding-ISS-  
GO:0045296cadherin binding-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000281mitotic cytokinesis-IMP14757759  17620337  
GO:0006888ER to Golgi vesicle-mediated transport-TAS-  
GO:0007009plasma membrane organization-IMP17620337  
GO:0007016cytoskeletal anchoring at plasma membrane-TAS7836469  
GO:0007165signal transduction-IEA-  
GO:0007409axonogenesis-ISS-  
GO:0007528neuromuscular junction development-ISS-  
GO:0010628positive regulation of gene expression-ISS18180363  
GO:0010650positive regulation of cell communication by electrical coupling-ISS-  
GO:0010765positive regulation of sodium ion transport-ISS18180363  
GO:0010960magnesium ion homeostasis-ISS-  
GO:0019228neuronal action potential-ISS-  
GO:0034112positive regulation of homotypic cell-cell adhesion-ISS-  
GO:0043001Golgi to plasma membrane protein transport-IMP17620337  
GO:0043266regulation of potassium ion transport-ISS-  
GO:0045184establishment of protein localization-IMP15611082  
GO:0045838positive regulation of membrane potential-ISS18180363  
GO:0050808synapse organization-IBA21873635  
GO:0071286cellular response to magnesium ion-ISS-  
GO:0071709membrane assembly-IMP14757759  17620337  
GO:0071709membrane assembly-ISS-  
GO:0072659protein localization to plasma membrane-IBA21873635  
GO:0072659protein localization to plasma membrane-IGI18180363  
GO:0072659protein localization to plasma membrane-IMP14757759  17620337  
GO:0072659protein localization to plasma membrane-ISS-  
GO:0072660maintenance of protein location in plasma membrane-IGI17620337  
GO:0090314positive regulation of protein targeting to membrane-ISS-  
GO:0099612protein localization to axon-IBA21873635  
GO:1900827positive regulation of membrane depolarization during cardiac muscle cell action potential-ISS18180363  
GO:1902260negative regulation of delayed rectifier potassium channel activity-ISS-  
GO:2000651positive regulation of sodium ion transmembrane transporter activity-ISS18180363  
GO:2001259positive regulation of cation channel activity-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005764lysosome-IEA-  
GO:0005783endoplasmic reticulum-TAS8666667  
GO:0005794Golgi apparatus-IEA-  
GO:0005829cytosol-TAS-  
GO:0005886plasma membrane-IDA-  
GO:0005886plasma membrane-ISS-  
GO:0005923bicellular tight junctioncolocalizes_withIDA14757759  
GO:0009925basal plasma membranecolocalizes_withIDA21223964  
GO:0009986cell surface-ISS21223964  
GO:0014704intercalated disc-IBA21873635  
GO:0014704intercalated disc-ISS-  
GO:0014731spectrin-associated cytoskeleton-ISS-  
GO:0016020membrane-IBA21873635  
GO:0016323basolateral plasma membrane-IDA15611082  
GO:0016328lateral plasma membrane-IDA14757759  
GO:0016529sarcoplasmic reticulum-ISS-  
GO:0030018Z disc-ISS-  
GO:0030315T-tubule-ISS-  
GO:0030425dendrite-ISS-  
GO:0031594neuromuscular junction-ISS-  
GO:0033268node of Ranvier-IBA21873635  
GO:0033268node of Ranvier-ISS-  
GO:0033270paranode region of axon-IBA21873635  
GO:0042383sarcolemma-IDA21223964  
GO:0043005neuron projection-ISS-  
GO:0043034costamere-TAS21223964  
GO:0043194axon initial segment-IBA21873635  
GO:0043194axon initial segment-IDA27356871  
GO:0043194axon initial segment-ISS-  
GO:0045202synapse-IBA21873635  
GO:0045211postsynaptic membrane-ISS-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1266738Developmental BiologyTAS
R-HSA-1266738Developmental BiologyIEA
R-HSA-199977ER to Golgi Anterograde TransportTAS
R-HSA-199991Membrane TraffickingTAS
R-HSA-373760L1CAM interactionsTAS
R-HSA-373760L1CAM interactionsIEA
R-HSA-392499Metabolism of proteinsTAS
R-HSA-422475Axon guidanceTAS
R-HSA-422475Axon guidanceIEA
R-HSA-445095Interaction between L1 and AnkyrinsTAS
R-HSA-445095Interaction between L1 and AnkyrinsIEA
R-HSA-446203Asparagine N-linked glycosylationTAS
R-HSA-5653656Vesicle-mediated transportTAS
R-HSA-597592Post-translational protein modificationTAS
R-HSA-6807878COPI-mediated anterograde transportTAS
R-HSA-948021Transport to the Golgi and subsequent modificationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28264723Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome. (2017 Mar 7)Lin XBMC Med
27994470Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data. (2016)Liu YOnco Targets Ther
25129674Ethanol treatment of lymphoblastoid cell lines from alcoholics and non-alcoholics causes many subtle changes in gene expression. (2014 Sep)McClintick JNAlcohol